Skip to content
MedsAcross

Brand family

Sprycel

Dasatinib · ER Squibb & Sons
United States
Presentations
6
Markets
1

Sprycel is a brand of Dasatinib marketed by ER Squibb & Sons, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Dasatinib
Brand owner
ER Squibb & Sons
Registered in
United States
Strengths and forms
100 mg tablet, 140 mg tablet, 20 mg tablet, 50 mg tablet, 70 mg tablet, 80 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Sprycel 100 mg tabletOralER Squibb & SonsUS FDAAvailable on request
Sprycel 140 mg tabletOralER Squibb & SonsUS FDAAvailable on request
Sprycel 20 mg tabletOralER Squibb & SonsUS FDAAvailable on request
Sprycel 50 mg tabletOralER Squibb & SonsUS FDAAvailable on request
Sprycel 70 mg tabletOralER Squibb & SonsUS FDAAvailable on request
Sprycel 80 mg tabletOralER Squibb & SonsUS FDAAvailable on request

Equivalent brands

Other brands of Dasatinib.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Sprycel

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.